New Research Demonstrate Biogen’s Continued Commitment to Improve Care of Patients with Multiple Sclerosis Across Treatment SpectrumGlobeNewsWire • 09/12/19
New Data Presented at ECTRIMS Reinforce Long-term Benefits of TECFIDERA® (dimethyl fumarate) Over 10 YearsGlobeNewsWire • 09/11/19
Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for PatientsGlobeNewsWire • 08/20/19
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/23/19